SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-23-034000
Filing Date
2023-04-28
Accepted
2023-04-28 17:22:32
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2022a1_180lifesci.htm   iXBRL 10-K/A 430801
2 CERTIFICATION f10k2022a1ex31-3_180life.htm EX-31.3 2832
3 CERTIFICATION f10k2022a1ex31-4_180life.htm EX-31.4 2764
4 GRAPHIC image_001.jpg GRAPHIC 4854
  Complete submission text file 0001213900-23-034000.txt   755706

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20221231.xsd EX-101.SCH 3249
6 XBRL DEFINITION FILE atnf-20221231_def.xml EX-101.DEF 16545
7 XBRL LABEL FILE atnf-20221231_lab.xml EX-101.LAB 33873
8 XBRL PRESENTATION FILE atnf-20221231_pre.xml EX-101.PRE 17563
10 EXTRACTED XBRL INSTANCE DOCUMENT f10k2022a1_180lifesci_htm.xml XML 7405
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38105 | Film No.: 23868428
SIC: 2834 Pharmaceutical Preparations